fbpx
Guilherme V. Silva, MD

Guilherme Vianna Silva, MD, is Director of Structural Heart Disease at Baylor College of Medicine and at The Texas Heart Institute, and Assistant Professor at Baylor College of Medicine. Dr. Silva is board certified in Cardiovascular Disease, Interventional Cardiology, Internal Medicine, Nuclear Cardiology and Echocardiography. Show full bio

 

Dr. Silva earned his medical degree from the Federal University of Rio de Janeiro in Brazil in December of 1994. Upon completing his medical degree, he did three years of Cardiology training in Brazil. After coming to the United States, he completed three years of postgraduate training in Internal Medicine at The University of Texas-Houston. At the Texas Heart Institute in Houston, Silva completed four years (June 2003 – June 2007) of fellowship in Research and Adult Cardiology. During his training at the Texas Heart Institute, Dr. Silva held the position of Chief Cardiology Fellow and was given The Tauber Award for the Outstanding Cardiology Fellow of the 2007 graduating class. From July of 2007 to June of 2008, Dr. Silva completed his Interventional Cardiology Fellowship at the Texas Heart Institute and again held the position of Chief Interventional Cardiology Fellow. Finally, Dr. Silva completed a fellowship at the Massachusetts General Hospital/Harvard Medical School in Structural Heart Disease from July 2012 to July 2013.

The major focus of Dr. Silva has been in cardiovascular disease research and is one of the pioneers in the utilization of stem cells for treating heart attacks and heart failure. With over 40 full papers published in the peer-reviewed literature, over 100 abstracts, and 13 books and book chapters along with multiple invitations to teach in the United States and South America are a testimony of his commitment to clinical research and patient care. Dr. Silva’s academic work includes topics such as: stem cell therapy for heart disease, interventional cardiology, coronary imaging, and structural heart disease interventions.

Dr. Silva is an expert in complex interventional cardiology procedures, including; cardiac catheterization, percutaneous transluminal coronary angioplasty (PTCA), coronary stenting, peripheral vascular angioplasty and stenting, and rotational atherectomy. He has also specially trained in structural heart disease interventions and performs procedures such as Transcatheter Aortic Valve Replacement (TAVR), Percutaneous Patent Foramen Ovale (PFO) closure and Percutaneous Atrial septal Defect (ASD) closure and Percutaneous closure of Paraprosthetic Valvular Leaks repairs. Lastly, Dr. Silva also specializes on percutaneous techniques to treat Mitral Valve Disease. He also specializes in MitraClip, a less-invasive treatment option for certain people with mitral regurgitation who are not suitable for surgery.

See Publications

Texas Heart Institute Positions

  • Director, Structural Heart Disease Program, THI Leadership
  • Teaching Staff, Cardiovascular Disease Fellowship
  • Teaching Staff, Interventional Cardiology Fellowship
  • Editorial Consultant, Texas Heart Institute Journal

Interests

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Disease
  • Structural Heart Disease Interventions

Education

  • Medical School:

    Federal University of Rio de Janeiro

  • Internship:

    University of Texas Health Science Center

  • Residency:

    University of Texas Health Science Center

  • Fellowships:

    Baylor College of Medicine
    Texas Heart Institute

Academic & Clinical Affiliations

  • Baylor College of Medicine
  • Baylor St. Luke's Medical Center

Certifications

  • American Board of Internal Medicine

Honors, Awards and Memberships

Publications

Forrest, J. K., Deeb, G. M., Yakubov, S. J. et al. (2023). 3-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis. J Am Coll Cardiol 81, 1663–1674. https://doi.org/10.1016/j.jacc.2023.02.017.
Gao, F., Kherallah, R., Koetting, M. et al. (2023). Leadless pacemaker with transcatheter aortic valve implantation: A single-center experience. Pacing Clin Electrophysiol. https://doi.org/10.1111/pace.14702.
Hamid, N., Jorde, U. P., Reisman, M. et al. (2023). Transcatheter left ventricular restoration in patients with heart failure. J Card Fail, S1071-9164(23)00070–2. https://doi.org/10.1016/j.cardfail.2023.03.003.
Patel, V., Gray, Z., Alam, M. et al. (2022). Peripheral extracorporeal membrane oxygenation support expands the application of robot-assisted coronary artery bypass. JTCVS Tech 13, 92–100. https://doi.org/10.1016/j.xjtc.2022.02.034.
Shah, S. J., Borlaug, B. A., Chung, E. S. et al. (2022). Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet, S0140-6736(22)00016–2. https://doi.org/10.1016/S0140-6736(22)00016-2.
Kherallah, R. Y., Koneru, S., Krajcer, Z. et al. (2021). Hemodynamic outcomes after valve-in-valve transcatheter aortic valve replacement: a single-center experience. Ann Cardiothorac Surg 10, 630–640. https://doi.org/10.21037/acs-2021-tviv-131.
Kherallah, R. Y., Harrison, D., Preventza, O. et al. (2021). Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis. Int J Cardiol 329, 50–55. https://doi.org/10.1016/j.ijcard.2020.12.054.
Nazir, S., Hahn, J., Minhas, A. M. et al. (2021). Association of Type 2 myocardial infarction with outcomes and resource utilization in patients undergoing endovascular transcatheter aortic valve replacement. Cardiovasc Revasc Med, S1553-8389(21)00140–8. https://doi.org/10.1016/j.carrev.2021.03.006.
Mahtta, D., Sudhakar, D., Koneru, S. et al. (2020). Targeting inflammation after myocardial infarction. Curr Cardiol Rep 22, 110. https://doi.org/10.1007/s11886-020-01358-2.
Gold, B. M., Parekh, D. R., Kearney, D. L. et al. (2019). Forme Fruste cor triatriatum dexter by transesophageal echocardiography and its impact on percutaneous heart procedures: a case series. CASE (Phila) 3, 189–199. https://doi.org/10.1016/j.case.2019.05.004.